Reporting to the Chief Scientific Officer, the Head of Preclinical Development will be responsible for leading the R&D of ExeVir Bio’s pipeline. The individual will develop strategic and operational plans to efficiently progress the company’s research projects from early discovery to pre-clinical proof-of-concept, lead candidate selection and subsequent nonclinical development studies to generate the nonclinical data packages required to support IND applications and the initiation of FIH studies. The Head of Preclinical Development will lead a team of scientists, associate scientists and laboratory technicians and oversees the design and conduct of all nonclinical studies/activities, including antibody discovery and characterization of the pharmacodynamic, pharmacokinetic, non-clinical safety and toxicological properties required to progress pipeline candidate compounds to clinical candidate declaration.

The role requires strong leadership skills, strategic insight and a background in antibody discovery and nonclinical development, with experience in study design, data evaluation, preparation of study reports and other written documentation of preclinical data and contributing to regulatory documents such as IB, IND applications and/or scientific advice briefing books. This position offers the opportunity to contribute strategic thinking, scientific knowledge as well as project and people management skills to a collaborative and dynamic team in a small start-up company. Efficiency, enthusiasm, reliability and pro-active mindset are a must to thrive in this fast-paced, challenging environment where all must take a hands-on approach to get things done.

Send us your application via mail or apply on LinkedIn.